Cited by 1,709Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacySynthesis of β-Lactam Compounds

The DOI matches its Crossref record; 462 of the 464 references it cites were found in a registry or an index.

Three Decades of β-Lactamase Inhibitors

Open access

Drawz, Sarah M., Bonomo, Robert A.·2010·Clinical Microbiology Reviews

Open this paper in CoChat — free account

Abstract

Since the introduction of penicillin, beta-lactam antibiotics have been the antimicrobial agents of choice. Unfortunately, the efficacy of these life-saving antibiotics is significantly threatened by bacterial beta-lactamases. beta-Lactamases are now responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems. In order to overcome beta-lactamase-mediated resistance, beta-lactamase inhibitors (clavulanate, sulbactam, and tazobactam) were introduced into clinical practice. These inhibitors greatly enhance the efficacy of their partner beta-lactams (amoxicillin, ampicillin, piperacillin, and ticarcillin) in the treatment of serious Enterobacteriaceae and penicillin-resistant staphylococcal infections. However, selective pressure from excess antibiotic use accelerated the emergence of resistance to beta-lactam-beta-lactamase inhibitor combinations. Furthermore, the prevalence of clinically relevant beta-lactamases from other classes that are resistant to inhibition is rapidly increasing. There is an urgent need for effective inhibitors that can restore the activity of beta-lactams. Here, we review the catalytic mechanisms of each beta-lactamase class. We then discuss approaches for circumventing beta-lactamase-mediated resistance, including properties and characteristics of mechanism-based inactivators. We next highlight the mechanisms of action and salient clinical and microbiological features of beta-lactamase inhibitors. We also emphasize their therapeutic applications. We close by focusing on novel compounds and the chemical features of these agents that may contribute to a "second generation" of inhibitors. The goal for the next 3 decades will be to design inhibitors that will be effective for more than a single class of beta-lactamases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/cmr.00037-09

Cites

462 of 462 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Extended-Spectrum β-Lactamases: a Clinical Update
Paterson, D. L., & Bonomo, R. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.4.657-686.2005 · Cited by 3,495
Self-citation
Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,646
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,609
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,485
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,328
AmpC β-Lactamases
Jacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,277
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,068
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,619
Prevention of Drug Access to Bacterial Targets: Permeability Barriers and Active Efflux
Nikaido, H. (1994) · Science · doi:10.1126/science.8153625 · Cited by 1,542

Show all 464 references

Research works printed but not linked: 14

Danel, F., M. G. Page, and D. M. Livermore. 2007. Class D β-lactamases, p. 163-194. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Dubus, A., P. Ledent, J. Lamotte-Brasseur, and J. M. Frere. 1996. The roles of residues Tyr150, Glu272, and His314 in class C β-lactamases. Proteins25:473-485.
Foulds, G., W. E. Barth, J. R. Bianchine, A. R. English, D. Girard, S. L. Hayes, M. O'Brien, and P. Somani. 1980. Pharmacokinetics of CP-45.899 and pro-drug CP-47.904 in animals and humans, p. 353-356. In J. D. Nelson and C. Grassi (ed.), Current chemotherapy and infectious disease. American Society for Microbiology, Washington DC.
Galleni, M., and J. M. Frere. 2007. Kinetics of β-lactamases and pencillin-binding proteins, p. 195-213. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washington, DC.
F1-310. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-333a. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Livermore, D. M., M. Akova, P. J. Wu, and Y. J. Yang. 1989. Clavulanate and β-lactamase induction. J. Antimicrob. Chemother.24(Suppl. B):23-33.
A1-006. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother. 2009
Meroueh, S., J. Cha, and S. Mobashery. 2007. Inhibition of class A β-lactamases, p. 101-114. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for inhibition. ASM Press, Washingtion, DC.
Page, M. G. 2007. Resistance mediated by penicllin-binding proteins, p. 81-99. In R. A. Bonomo and M. E. Tolmasky (ed.), Enzyme-mediated resistance to antibiotics: mechanisms, dissemination, and prospects for Inhibition. ASM Press, Washington, DC.
F1-311. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
F1-0882. Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. 2007
Slocombe, B., A. S. Beale, R. J. Boon, K. E. Griffin, P. J. Masters, R. Sutherland, and A. R. White. 1984. Antibacterial activity in vitro and in vivo of amoxicillin in the presence of clavulanic acid, p. 29-49. InProgress and perspectives on β-lactamase inhibition: a review of Augmentin. Custom Communications: Postgraduate Medicine, New York, NY.

Sorted by citations

Items 801–900 of 1,001

Insight into the Mechanism of Hydrolysis of Meropenem by OXA-23 Serine-β-lactamase Gained by Quantum Mechanics/Molecular Mechanics Calculations
Sgrignani, J., Grazioso, G., & Amici, M. D. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00461 · Cited by 17
Rethinking the Role of Natural Products: Function‐Oriented Synthesis, Bryostatin, and Bryologs
Wender, P. A., Donnelly, A. C., Loy, B. A., Near, K. E., & Staveness, D. (2014) · Methods and principles in medicinal chemistry · doi:10.1002/9783527676545.ch14 · Cited by 17
A comprehensive computational study to explore promising natural bioactive compounds targeting glycosyltransferase MurG in Escherichia coli for potential drug development
Shtaiwi, A., Khan, S. U., Khedraoui, M., Alaraj, M., Samadi, A., & Chtita, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-57702-x · Cited by 16
Promising Future of Novel Beta-Lactam Antibiotics Against Bacterial Resistance
Tayeb, S. M., Alharbi, J., Alattas, B., Al-Otaibi, D. S., Althibaiti, N., Alharbi, J., SafirAldeen, A., Alqurashi, I. M., & Wali, S. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s551862 · Cited by 16
The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli
Roach, E. J., Uehara, T., Daigle, D. M., Six, D. A., & Khursigara, C. M. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00918-21 · Cited by 16
Overcoming Beta-Lactamase-Based Antimicrobial Resistance by Nanocarrier-Loaded Clavulanic Acid and Antibiotic Cotreatments
Filby, B. W., Weldrick, P. J., & Paunov, V. N. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00369 · Cited by 16
Limosilactobacillus fermentum Strain 3872: Antibacterial and Immunoregulatory Properties and Synergy with Prebiotics against Socially Significant Antibiotic-Resistant Infections of Animals and Humans
Abramov, V. M., Kosarev, I. V., Валериевич, М. А., Priputnevich, T. V., Chikileva, I. O., Deryusheva, E. I., Abashina, T. N., Дмитриевна, Д. А., Панин, А. Н., Melnikov, V. G., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101437 · Cited by 15
Role of blaTEM and OmpC in the piperacillin-tazobactam resistance evolution by E. coli in patients with complicated intra-abdominal infection
Gálvez-Benítez, L., de la Rosa, J. M. O., Rodríguez-Villodres, Á., Casimiro‐Soriguer, C. S., Panadero, I. M., Álvarez‐Marín, R., Bonnin, R. A., Naas, T., Pachón, J., Cisneros, J. M., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.07.005 · Cited by 16
Activity of Ceftaroline-Avibactam Tested Against Contemporary Enterobacteriaceae Isolates Carrying β-Lactamases Prevalent in the United States
Castanheira, M., Williams, G. B., Jones, R. N., & Sader, H. S. (2014) · Microbial Drug Resistance · doi:10.1089/mdr.2013.0181 · Cited by 16
Modified Penicillin Molecule with Carbapenem-Like Stereochemistry Specifically Inhibits Class C β-Lactamases
Pan, X., He, Y., Chen, T., Chan, K., & Zhao, Y. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01288-17 · Cited by 16
OXA-72-Mediated Carbapenem Resistance in Sequence Type 1 Multidrug (Colistin)-Resistant Acinetobacter baumannii Associated with Urinary Tract Infection in a Dog from Serbia
Mišić, D., Ašanin, J., Spergser, J., Szostak, M. P., & Loncaric, I. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00219-18 · Cited by 16
Pd‐Catalyzed Asymmetric Allylic Substitution Annulation Using Enolizable Ketimines as Nucleophiles: An Alternative Approach to Chiral Tetrahydroindoles
Xu, K., Ye, J., Liu, H., Shen, J., Liu, D., & Zhang, W. (2020) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202000151 · Cited by 16
Measures used to assess the burden of ESBL-producing Escherichia coli infections in humans: a scoping review
McDonald, K., Garland, S., Carson, C. A., Gibbens, K., Parmley, E. J., Finley, R. L., & MacKinnon, M. C. (2020) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlaa104 · Cited by 16
The Role of Hydrophobic Nodes in the Dynamics of Class A β-Lactamases
Olehnovics, E., Yin, J., Pérez, A., Fabritiis, G. D., Bonomo, R. A., Bhowmik, D., & Haider, S. M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.720991 · Cited by 16
Self-citation
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa
Cabot, G., Kim, K., Mark, B. L., Oliver, A., & Khajehpour, M. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01409-22 · Cited by 16
Identification of benzochromene derivatives as a highly specific NorA efflux pump inhibitor to mitigate the drug resistant strains of S. aureus
Ganesan, A., Christena, L. R., Makala, H., Ulaganathan, V., Raman, T., Venkatabalasubramanian, S., Kasilingam, K., Nagarajan, S., & Ganesan, S. S. (2016) · RSC Advances · doi:10.1039/c6ra01981a · Cited by 16
Theoretical exploration of mechanism of carbapenam formation in catalytic Kinugasa reaction
Darroudi, M., Sarrafi, Y., & Hamzehloueian, M. (2017) · Tetrahedron · doi:10.1016/j.tet.2017.01.071 · Cited by 16
Investigation of common chemical components and inhibitory effect on GES-type β-lactamase (GES22) in methanolic extracts of Algerian seaweeds
Houchi, S., Mahdadi, R., Khenchouche, A., Song, J., Zhang, W., Pang, X., Zhang, L., Sandallı, C., & Du, G. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.10.034 · Cited by 16
A novel framework to compare the effectiveness of β-lactamase inhibitors against extended-spectrum β-lactamase-producing Enterobacteriaceae
Abodakpi, H., Chang, K., Zhou, J., Byerly, C. D., & Tam, V. H. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.01.003 · Cited by 16
Potential Inhibitors Against NDM-1 Type Metallo-β-Lactamases: An Overview
Sharma, S., Sharma, S., Singh, P. P., & Khan, I. A. (2020) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0315 · Cited by 16
Inhibition of Class A β-Lactamase (TEM-1) by Narrow Fractions of Humic Substances
Mikhnevich, T. A., Vyatkina, A. V., Григоренко, В. Г., Rubtsova, M. Y., Rukhovich, G. D., Letarova, M. A., Kravtsova, D. S., Vladimirov, S. A., Orlov, A. A., Николаев, Е. Н., et al. (2021) · ACS Omega · doi:10.1021/acsomega.1c02841 · Cited by 16
An approach to identifying drug resistance associated mutations in bacterial strains
Woźniak, M., Tiuryn, J., & Wong, L. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-s7-s23 · Cited by 16
HR-LCMS profiling, in vitro and in silico assessment of the antibacterial activities of endophytic Bacillus amyloliquefaciens NWR-14 from Piper chaba W. Hunter
Asokan, S., Jacob, T., Cherian, T., Merlin, T., Vivekanandhan, S., AlSosowaa, A. A., Atiyah, M. M., Al-Mojahid, F. Q., Peijnenburg, W. J. G. M., & Vijayan, S. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100885 · Cited by 15
The physiological and ecological properties of bacterial persisters discovered from municipal sewage sludge and the potential risk
Liu, X., Tang, R., Li, H., Wang, L., & Wan, C. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112481 · Cited by 15
Epidemiology and In Vitro Activity of Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam against KPC-Producing K. pneumoniae Collected from Bacteremic Patients, 2018 to 2020
Bovo, F., Lombardo, D., Lazzarotto, T., Ambretti, S., & Gaibani, P. (2022) · Antibiotics · doi:10.3390/antibiotics11111621 · Cited by 15
β‐Lactam antimicrobials: what have you done for me lately?
Talbot, G. H. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06809.x · Cited by 15
Effects of geometrical confinement in membrane pores on enzyme-based layer-by-layer assemblies
Ramírez-Wong, D. G., Coelho, C., Aimé, C., Bonhomme, C., Jonas, A. M., & Demoustier‐Champagne, S. (2015) · Applied Surface Science · doi:10.1016/j.apsusc.2015.02.123 · Cited by 15
Deletion Mutations Conferring Substrate Spectrum Extension in the Class A β-Lactamase
Hwang, J., Cho, K.-H., Song, H., Yi, H., & Kim, H. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02648-14 · Cited by 15
SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
Winkler, M., & Bonomo, R. A. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv235 · Cited by 15
Self-citation
Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam–β-Lactamase Inhibitor Combinations
Soon, R. L., Lenhard, J. R., Bulman, Z. P., Holden, P. N., Kelchlin, P. A., Steenbergen, J. N., Friedrich, L. V., Forrest, A., & Tsuji, B. T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02635-15 · Cited by 15
Kinetic characterization and molecular docking of novel allosteric inhibitors of aminoglycoside phosphotransferases
Leban, N., Kaplan, E., Chaloin, L., Godreuil, S., & Lionne, C. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.012 · Cited by 15
A potent synthetic inorganic antibiotic with activity against drug-resistant pathogens
Hubick, S., Jayaraman, A., McKeen, A., Reid, S., Alcorn, J., Stavrinides, J., & Sterenberg, B. T. (2017) · Scientific Reports · doi:10.1038/srep41999 · Cited by 15
PEG-8 Laurate Fermentation of Staphylococcus epidermidis Reduces the Required Dose of Clindamycin Against Cutibacterium acnes
Marito, S., Keshari, S., & Huang, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145103 · Cited by 17
Thiosemicarbazones exhibit inhibitory efficacy against New Delhi metallo-β-lactamase-1 (NDM-1)
Ge, Y., Kang, P.-W., Li, J., Gao, H., Zhai, L., Sun, L.-Y., Chen, C., & Yang, K. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00440-3 · Cited by 15
What are the missing pieces needed to stop antibiotic resistance?
Martínez, J. L., & Baquero, F. (2023) · Microbial Biotechnology · doi:10.1111/1751-7915.14310 · Cited by 16
Irreversible inactivation of snake venom l ‐amino acid oxidase by covalent modification during catalysis of l ‐propargylglycine
Mitra, J., & Bhattacharyya, D. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.01.010 · Cited by 15
Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs ofEscherichia coli
Geyer, C. N., Fowler, R. C., Johnson, J. R., Johnston, B., Weissman, S. J., Hawkey, P. M., & Hanson, N. D. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv388 · Cited by 15
A Dimer, but Not Monomer, of Tobramycin Potentiates Ceftolozane against Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa and Delays Resistance Development
Idowu, T., Zhanel, G. G., & Schweizer, F. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02055-19 · Cited by 15
Structure-based design of covalent inhibitors targeting metallo-β-lactamases
Chen, C., & Yang, K. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112573 · Cited by 15
Heterogeneous Catalysis with Basic Compounds to Achieve the Synthesis and C–N Cleavage of Azetidin-2-ones under Microwave Irradiation
Galván, A., de la Cruz, F. N., Cruz, F., Martı́nez, M., Gómez, C. V., Alcaraz‐Contreras, Y., Domínguez-Esquivel, J. M., Delgado, F., & Vazquez, M. A. (2019) · Synthesis · doi:10.1055/s-0037-1611851 · Cited by 14
Molecular mechanisms leading to ceftolozane/tazobactam resistance in clinical isolates of Pseudomonas aeruginosa from five Latin American countries
Mojica, M. F., Cadena, E. D. L., Ríos, R., García-Betancur, J. C., Díaz, L., Reyes, J., Hernández-Gómez, C., Radice, M. A., Gales, A. C., Castañeda-Méndez, P., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1035609 · Cited by 14
Distinct Inhibition Modes of New Delhi Metallo-β-lactamase-1 Revealed by NMR Spectroscopy
Cheng, K., Wu, Q. S., Yao, C., Chai, Z., Jiang, L. Y., Liu, M., & Li, C. (2023) · JACS Au · doi:10.1021/jacsau.2c00651 · Cited by 14
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas -derived cephalosporinase
Mack, A. R., Kumar, V., Taracila, M. A., Mojica, M. F., O'Shea, M., Schinabeck, W., Silver, G., Hujer, A. M., Papp‐Wallace, K. M., Chen, S., et al. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00791-23 · Cited by 14
Self-citation
The Triple Combination of Meropenem, Avibactam, and a Metallo-β-Lactamase Inhibitor Optimizes Antibacterial Coverage Against Different β-Lactamase Producers
Ling, Z., Farley, A. J. M., Lankapalli, A. K., Zhang, Y., Premchand-Branker, S., Cook, K. F., Baran, A. G., Gray-Hammerton, C. J., Rubio, C. O., Sūna, E., et al. (2024) · Engineering · doi:10.1016/j.eng.2024.02.010 · Cited by 14
Development of Nanomaterials‐Based Agents for Selective Antibacterial Activity
Kaur, N., Sahoo, J., & De, M. (2024) · ChemBioChem · doi:10.1002/cbic.202400693 · Cited by 14
Insights on the structural characteristics of NDM-1: The journey so far
Saini, A., & Bansal, R. (2012) · Advances in Biological Chemistry · doi:10.4236/abc.2012.24040 · Cited by 14
A telescopic one-pot synthesis of β-lactam rings using amines as a convenient source of imines
Rajamäki, S., Luca, L. D., Capitta, F., & Porcheddu, A. (2016) · RSC Advances · doi:10.1039/c6ra02744j · Cited by 14
A Fluorescent Transport Assay Enables Studying AmpG Permeases Involved in Peptidoglycan Recycling and Antibiotic Resistance
Perley-Robertson, G. E., Yadav, A. K., Winogrodzki, J. L., Stubbs, K. A., Mark, B. L., & Vocadlo, D. J. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00552 · Cited by 14
Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods
Teethaisong, Y., Eumkeb, G., Chumnarnsilpa, S., Autarkool, N., Hobson, J., Nakouti, I., Hobbs, G., & Evans, K. E. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000326 · Cited by 14
Structural and mechanistic insights into the inhibition of class C β-lactamases through the adenylylation of the nucleophilic serine
Kim, M., An, Y. J., Na, J., Seol, J.-H., Ryu, J. Y., Lee, J., Kang, L., Chung, K. M., Lee, J., Moon, J. H., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw491 · Cited by 14
Synthesis, SAR and molecular docking study of novel non-β-lactam inhibitors of TEM type β-lactamase
Antipin, R. L., Beshnova, D. A., Petrov, R. A., Shiryaeva, A. S., Andreeva, I. P., Grigorenko, G. M., Rubtsova, M. Y., Majouga, A. G., Lamzin, V. S., & Egorov, A. M. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.02.025 · Cited by 14
Fluorescence Resonance Energy Transfer-Mediated Immunosensor Based on Design and Synthesis of the Substrate of Amp Cephalosporinase for Biosensing
Deng, S., Wu, J., Zhang, K., Li, Y., Yang, L., Hu, D., Jin, Y., Hao, Y., Wang, X., Liu, Y., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02427 · Cited by 14
The Phylogenetic Relatedness of blaNDM-1 Harboring Extended-Spectrum β-Lactamase Producing Uropathogenic Escherichia coli and Klebsiella pneumoniae in the North of Iran
Jamali, S., Tavakoly, T., Mojtahedi, A., & Shenagari, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s230335 · Cited by 14
Characterization of the Inhibitor-Resistant SHV β-Lactamase SHV-107 in a Clinical Klebsiella pneumoniae Strain Coproducing GES-7 Enzyme
Manageiro, V., Ferreira, E., Cougnoux, A., Albuquerque, L., Caniça, M., & Bonnet, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-10 · Cited by 14
Mechanisms and Detection of Antimicrobial Resistance
Alby, K., & Miller, M. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00290-5 · Cited by 14
Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus
Yang, S., Pan, J., Yang, C., Labroli, M. A., Pan, W., Caldwell, J. P., Ha, S., Koseoglu, S., Xiao, J. C., Mayhood, T., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.08.036 · Cited by 14
The structure of Toho1 β‐lactamase in complex with penicillin reveals the role of Tyr105 in substrate recognition
Langan, P. S., Vandavasi, V. G., Weiss, K. L., Cooper, J. B., Ginell, S. L., & Coates, L. (2016) · FEBS Open Bio · doi:10.1002/2211-5463.12132 · Cited by 14
Resensitization of methicillin-resistant Staphylococcus aureus by amoxapine, an FDA-approved antidepressant
Wilson, T. J., Blackledge, M. S., & Vigueira, P. A. (2018) · Heliyon · doi:10.1016/j.heliyon.2017.e00501 · Cited by 14
Targeting a hidden site on class A beta-lactamases
Avcı, F. G., Kaya, F. E. A., Karacan, I., Karagoz, D. S., Ersahin, S., Eren, A., Sayar, N. A., Vardar‐Ulu, D., Özkırımlı, E., & Akbulut, B. S. (2018) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2018.06.007 · Cited by 14
Preparation of Carbon-14 Labeled 2-(2-mercaptoacetamido)-3-phenylpropanoic Acid as Metallo-beta-lactamases Inhibitor (MBLI), for Coadministration with Beta-lactam Antibiotics
Maleki, A. R., Taheri‐Ledari, R., Eivazzadeh‐Keihan, R., de la Guárdia, M., & Mokhtarzadeh, A. (2019) · Current Organic Synthesis · doi:10.2174/1570179416666190423114704 · Cited by 14
α‐Unsaturated 3‐Amino‐1‐carboxymethyl‐β‐lactams as Bacterial PBP Inhibitors: Synthesis and Biochemical Assessment
Decuyper, L., Magdalenić, K., Verstraete, M., Jukič, M., Sosič, I., Sauvage, E., Amoroso, A. M., Verlaine, O., Joris, B., Gobec, S., et al. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201904139 · Cited by 14
Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal
Sah, R., Khadka, S., Shrestha, G. S., Acharya, S. P., Aryal, D., Shrestha, P. S., Kattel, H. P., Shah, N. P., Pokhrel, B. M., Singh, Y. P., et al. (2019) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-019-0608-1 · Cited by 14
Structure-based computational study of the hydrolysis of New Delhi metallo-β-lactmase-1
Zhu, K., Lu, J., Ye, F., Lu, J., Kong, X., Liang, Z. T., Chen, Y., Yu, K., Jiang, H., Li, J., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.141 · Cited by 14
Exploiting the aggregation propensity of beta-lactamases to design inhibitors that induce enzyme misfolding
Khodaparast, L., Khodaparast, L., Wu, G., Michiels, E., Gallardo, R. U., Houben, B., Garcia, T., Vleeschouwer, M. D., Ramakers, M., Wilkinson, H. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41191-z · Cited by 13
Machine Learning and Deep Learning Models for Predicting Noncovalent Inhibitors of AmpC β-Lactamase
Bagdad, Y., Sisquellas, M., Arthur, M., & Miteva, M. A. (2024) · ACS Omega · doi:10.1021/acsomega.4c03834 · Cited by 14
Muropeptides and muropeptide transporters impact on host immune response
Delgado, M. L. O., Magalhaes, J. G., Morra, R., & Cultrone, A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2418412 · Cited by 14
Recent Applications of Artificial Intelligence in Discovery of New Antibacterial Agents
Bagdad, Y., & Miteva, M. A. (2024) · Advances and Applications in Bioinformatics and Chemistry · doi:10.2147/aabc.s484321 · Cited by 16
GMP and IMP Are Competitive Inhibitors of CMY-10, an Extended-Spectrum Class C β-Lactamase
Na, J., An, Y. J., & Cha, S. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00098-17 · Cited by 13
Antibacterial, modulatory activity of antibiotics and toxicity from Rhinella jimi (Stevaux, 2002) (Anura: Bufonidae) glandular secretions
Sales, D. L., Morais‐Braga, M. F. B., dos Santos, A. T. L., Machado, A. J. T., Filho, J. A. A., Dias, D. D. Q., da Cunha, F. A. B., Saraiva, R. D. A., de Menezes, I. R. A., Coutinho, H. D. M., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.098 · Cited by 13
Efficacy and safety of ceftazidime-avibactam in the treatment of complicated intra-abdominal infections (CIAIs) and complicated urinary tract infections (CUTIs): A meta-analysis of randomized controlled trials
Zhang, Y., Tao, L., Qu, X., Niu, J., Ding, Y., & Zhang, S. (2018) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.64.03.253 · Cited by 13
Study of the effectiveness of staphylococcins in biopreservation of Minas fresh (Frescal) cheese with a reduced sodium content
de Farias, F. M., Nascimento, J. D. S., Santos, O. C. D. S., & Bastos, M. D. C. D. F. (2019) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2019.05.014 · Cited by 15
Multifunctional metal-chelated phosphonate/Fe3O4 magnetic nanocomposite particles for defeating antibiotic-resistant bacteria
Akhlaghi, N., & Najafpour, G. D. (2021) · Powder Technology · doi:10.1016/j.powtec.2021.01.078 · Cited by 13
Triazole-substituted phenylboronic acids as tunable lead inhibitors of KPC-2 antibiotic resistance
Zhou, J., Stapleton, P. D., Júnior, F. H. X., Schätzlein, A. G., Haider, S. M., Healy, J., & Wells, G. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114571 · Cited by 13
Broad-Spectrum Inhibitors against Class A, B, and C Type β-Lactamases to Block the Hydrolysis against Antibiotics: Kinetics and Structural Characterization
Farhat, N., Gupta, D., Ali, A., Kumar, Y., Akhtar, F., Kulanthaivel, S., Mishra, P., Khan, F., & Khan, A. U. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00450-22 · Cited by 13
A novel fluorogenic substrate for dinuclear Zn(II)-containing metallo-β-lactamases
Yin-lin, Z., Xiao, J.-M., Feng, J.-L., Yang, K., Feng, L., Zhou, L., & Crowder, M. W. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.071 · Cited by 13
Substitutions at Position 105 in SHV Family β-Lactamases Decrease Catalytic Efficiency and Cause Inhibitor Resistance
Li, M., Conklin, B. C., Taracila, M. A., Hutton, R. A., & Skalweit, M. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00711-12 · Cited by 13
Structural basis for the extended substrate spectrum of AmpC BER and structure-guided discovery of the inhibition activity of citrate against the class C β-lactamases AmpC BER and CMY-10
Na, J., & Cha, S. (2016) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798316011311 · Cited by 13
Better living through chemistry: Addressing emerging antibiotic resistance
Coussens, N. P., Molinaro, A. L., Culbertson, K. J., Peryea, T., Zahoránszky-Köhalmi, G., Hall, M. D., & Daines, D. A. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218755659 · Cited by 13
Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative Bacteria
Skočibušić, M., Odžak, R., Ramić, A., Smolić, T., Hrenar, T., & Primožič, I. (2018) · Molecules · doi:10.3390/molecules23051212 · Cited by 13
Advances in Theoretical Studies on the Design of Single Boron Atom Compounds
Bello, M. (2018) · Current Pharmaceutical Design · doi:10.2174/1381612824666181102142432 · Cited by 13
Antibiotic Resistance Profile and Clonality of E. coli Isolated from Water and Paediatric Stool Samples in the North-West, Province South Africa
Chukwu, M. O., Abia, A. L. K., Ubomba‐Jaswa, E., Obi, L. C., & Dewar, J. B. (2019) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.13.1.58 · Cited by 13
Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamase
Rotondo, C. M., Marrone, L., Goodfellow, V. J., Ghavami, A., Labbé, G., SPENCER, J. M., Dmitrienko, G. I., & Siemann, S. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.07.012 · Cited by 13
Kinetics of Action of a Two-Stage Pro-Inhibitor of Serine β-Lactamases
Tilvawala, R. R., & Pratt, R. F. (2013) · Biochemistry · doi:10.1021/bi400873r · Cited by 13
Navigating the complexities of drug development for metallo-β-lactamase inhibitors
Reddy, N., Balieiro, A. M., Silva, J. R. A., Gouws, A. C., Mutshembele, A., Arvidsson, P. I., Kruger, H. G., Govender, T., & Naicker, T. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00035a · Cited by 15
Azetidines in medicinal chemistry: emerging applications and approved drugs
Cheekatla, S. R. (2026) · Future Medicinal Chemistry · doi:10.1080/17568919.2025.2610169 · Cited by 13
Integrating Forecast Probabilities in Antibiograms: a Way To Guide Antimicrobial Prescriptions More Reliably?
Maurer, F. P., Courvalin, P. M., Böttger, E. C., & Hombach, M. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01645-14 · Cited by 12
Variations in the SDN Loop of Class A Beta-Lactamases: A Study of the Molecular Mechanism of BlaC (Mycobacterium tuberculosis) to Alter the Stability and Catalytic Activity Towards Antibiotic Resistance of MBIs
Bhattacharya, S., Junghare, V., Pandey, N. K., Baidya, S., Agarwal, H., Das, N., Banerjee, A., Ghosh, D., Roy, P., Patra, H. K., et al. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.710291 · Cited by 12
Efficacy and safety of piperacillin–tazobactam compared with meropenem in treating complicated urinary tract infections including acute pyelonephritis due to extended-spectrum β-lactamase-producing Enterobacteriaceae
Zhang, W., Yan, C., Li, S.-R., Fan, T., Cao, S.-S., Cui, B., Li, M., Fan, B., Ji, B., Wang, L., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1093842 · Cited by 12
Augmenting Antimicrobial Resistance Surveillance: Rapid Detection of β-Lactamase-Expressing Drug-Resistant Bacteria through Sensitized Luminescence on a Paper-Supported Hydrogel
Dutta, A., Mukherjee, S., Haldar, J., & Maitra, U. (2023) · ACS Sensors · doi:10.1021/acssensors.3c02065 · Cited by 12
Deciphering the Coevolutionary Dynamics of L2 β-Lactamases via Deep Learning
Zhu, Y., Gu, J., Zhao, Z., Chan, A. W. E., Mojica, M. F., Hujer, A. M., Bonomo, R. A., & Haider, S. M. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00189 · Cited by 12
Self-citation
Investigation for antimicrobial resistance-modulating activity of diethyl malate and 1-methyl malate against beta-lactamase class A from Bacillus licheniformis by molecular dynamics, in vitro and in vivo studies
Mirzaie, S., Najafi, K., Hakhamaneshi, M. S., Shahverdi, A. R., & Fathi, F. (2014) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2014.924877 · Cited by 12
Antibiotics That Inhibit Cell Wall Synthesis
Bhattacharjee, M. K. (2016) · Springer eBooks · doi:10.1007/978-3-319-40746-3_3 · Cited by 11
Diastereoselective synthesis of 3-acetoxy-4-(3-aryloxiran-2-yl)azetidin-2-ones and their transformation into 3,4-oxolane-fused bicyclic β-lactams
Piens, N., Craene, S. D., Franceus, J., Mollet, K., Hecke, K. V., Desmet, T., & D’hooghe, M. (2016) · Organic & Biomolecular Chemistry · doi:10.1039/c6ob02221a · Cited by 12
Mercaptoacetate thioesters and their hydrolysate mercaptoacetic acids jointly inhibit metallo-β-lactamase L1
Chen, C., Yang, X., Liu, Y., Hu, X., & Yang, K. (2018) · MedChemComm · doi:10.1039/c8md00091c · Cited by 12
Systematic research of H2dedpa derivatives as potent inhibitors of New Delhi Metallo-β-lactamase-1
Cui, D.-Y., Yang, Y., Bai, M.-M., Han, J., Wang, C., Kong, H., Shen, B.-Y., Yan, D.-C., Xiao, C., Liu, Y., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103965 · Cited by 12
Systematic Parameterization and Simulation of Boronic Acid−β-Lactamase Aqueous Solution in Developing the ABEEMσπ Polarizable Force Field
Lu, L., Liu, C., & Yang, Z. (2020) · The Journal of Physical Chemistry A · doi:10.1021/acs.jpca.0c06806 · Cited by 12
The multiple benefits of second-generation β-lactamase inhibitors in treatment of multidrug-resistant bacteria
Coelho, F. D. S., & Mainardi, J. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2020.11.007 · Cited by 12
Multiresistant and blaCTX-M-14-Carrying Salmonella ser. Typhimurium Isolated During a Salmonellosis Outbreak in an Equine Hospital in Argentina
Bustos, C., Dominguez, J. E., Garda, D., Moroni, M., Molinari, N. P., Herrera, M., Chacana, P. A., & Mesplet, M. (2021) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2021.103404 · Cited by 12
Glycosylated Nanotherapeutics with β-Lactamase Reversible Competitive Inhibitory Activity Reinvigorates Antibiotics against Gram-Negative Bacteria
Sun, H., Yu, Y., Zhang, Y., Li, J., Cheng, Y., Huang, S., Wang, W., & Zhang, X. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00231 · Cited by 12
Semirapid Detection of Piperacillin/Tazobactam Resistance and Extended-Spectrum Resistance to β-Lactams/β-Lactamase Inhibitors in Clinical Isolates of Escherichia coli
Rodríguez-Villodres, Á., Linares, A. G., Gálvez-Benítez, L., Pachón, J., Lepe, J. A., & Smani, Y. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00801-21 · Cited by 12

Authors: Drawz, S. M., & Bonomo, R. A.
Affiliations: Departments of Pathology
United States Department of Veterans Affairs (US)
Corresponding author: Bonomo, Robert A.
ORCID: Bonomo, Robert A.
Venue: Clinical Microbiology Reviews
Publisher: American Society for Microbiology
Published: 2010-01
Volume: 23
Issue: 1
Pages: 160-201
ISSN: 0893-8512 (ISSN-L)
1098-6618
DOI: 10.1128/cmr.00037-09
PMC: PMC2806661
OpenAlex: W1895007034
Cited by: 1,709
References: 464
Citations by year: 2026: 83 · 2025: 100 · 2024: 87 · 2023: 86 · 2022: 106 · 2021: 126 · 2020: 151 · 2019: 130 · 2018: 131 · 2017: 119 · 2016: 120 · 2015: 108 · 2014: 93 · 2013: 88 · 2012: 81
FWCI: 4.26
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Clinical Microbiology Reviews (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Public Health Service (1R01A1063517-01)
National Institute of General Medical Sciences (T32GM007250, T32GM07250)
Topics: Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
Physical Sciences › Chemistry › Organic Chemistry › Synthesis of β-Lactam Compounds
Keywords: beta-lactamase inhibitors, beta-lactamase, beta-lactam resistance, clavulanic acid, sulbactam, tazobactam, mechanism-based inactivators, carbapenemase inhibitors, extended-spectrum cephalosporin resistance, Enterobacteriaceae, penicillin-resistant staphylococci
MeSH terms: Bacteria, Bacterial Infections, Bacterial Proteins, beta-Lactamases, Enzyme Inhibitors, Humans, beta-Lactam Resistance, beta-Lactamase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Three Decades of β-Lactamase Inhibitors

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks